{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:50:52Z","timestamp":1765295452263,"version":"3.41.2"},"reference-count":45,"publisher":"IMR Press","issue":"2","license":[{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background: Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by immune response mediated islet beta cells destruction. However, the mechanisms that cause immune response in TIDM are still under investigation. Therefore, the goal of this study was to investigate the role of advanced glycation end products (AGEs) in the regulation of the immune response in peripheral blood mononuclear cells (PBMCs) from patients with T1DM. Methods: PBMCs isolated from T1DM patients and control subjects were used in the current study. Cytokines, AGEs related to glyoxalase 1 (GLO1), methylglyoxal (MG)-derived AGEs were assessed longitudinally. Results: The results of published T1DM PBMC microarray datasets using random-effects meta-analysis models revealed immune responses in the PBMCs of patients with T1DM compared with control subjects. Moreover, the activity of GLO1, which is the key MG-metabolizing enzyme, was significantly reduced in PBMCs from T1DM patients. We confirmed that, compared to the control subjects, GLO1 expression and activity were markedly decreased and MG-derived AGEs were significantly accumulated in the PBMCs from T1DM patients. In addition, phytohemagglutinin stimulated the secretion of tumor necrosis factor alpha (TNF-\u03b1), and interferon gamma (IFN-\u03b3) was positively correlated with the accumulation of cellular AGEs. Therefore, the exposure of PBMCs from control subjects to MG and a GLO1 inhibitor enhanced the accumulation of cellular MG-derived AGEs and the secretion of TNF-\u03b1 and IFN-\u03b3. Conclusions: The results of this study showed that the accumulation of cellular AGEs causes a decline in the immune response of patients with T1DM.<\/jats:p>","DOI":"10.31083\/j.fbl2902085","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T08:19:30Z","timestamp":1708676370000},"source":"Crossref","is-referenced-by-count":2,"title":["Cellular Advanced Glycation End Products Aggravate the Immune Response in Mononuclear Cells from Patients with Type 1 Diabetes"],"prefix":"10.31083","volume":"29","author":[{"given":"Liang","family":"Yang","sequence":"first","affiliation":[{"name":"School of Basic Medical Science, Gansu Medical College, 744000 Pingliang, Gansu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxuan","family":"Qian","sequence":"first","affiliation":[{"name":"Department of Biology, School of Arts & Sciences, University of Rochester, Rochester, NY 14627, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shixin","family":"Lei","sequence":"first","affiliation":[{"name":"School of Basic Medical Science, Gansu Medical College, 744000 Pingliang, Gansu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongping","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine, The Affiliated Hospital of Gansu Medical College, 744000 Pingliang, Gansu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16242","published-online":{"date-parts":[[2024,2,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Knip M, Siljander H. Autoimmune mechanisms in type 1 diabetes. Autoimmunity Reviews. 2008; 7: 550\u2013557.","DOI":"10.1016\/j.autrev.2008.04.008"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Santos AS, Cunha-Neto E, Gonfinetti NV, Bertonha FB, Brochet P, Bergon A, et al. Prevalence of Inflammatory Pathways Over Immuno-Tolerance in Peripheral Blood Mononuclear Cells of Recent-Onset Type 1 Diabetes. Frontiers in Immunology. 2022; 12: 765264.","DOI":"10.3389\/fimmu.2021.765264"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nature Reviews. Endocrinology. 2009; 5: 219\u2013226.","DOI":"10.1038\/nrendo.2009.21"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"J\u00f6rns A, Arndt T, Meyer zu Vilsendorf A, Klempnauer J, Wedekind D, Hedrich HJ, et al. Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes. Diabetologia. 2014; 57: 512\u2013521.","DOI":"10.1007\/s00125-013-3125-4"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Padgett LE, Broniowska KA, Hansen PA, Corbett JA, Tse HM. The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis. Annals of the New York Academy of Sciences. 2013; 1281: 16\u201335.","DOI":"10.1111\/j.1749-6632.2012.06826.x"},{"key":"ref6","unstructured":"Duan W, Ding Y, Yu X, Ma D, Yang B, Li Y, et al. Metformin mitigates autoimmune insulitis by inhibiting Th1 and Th17 responses while promoting Treg production. American Journal of Translational Research. 2019; 11: 2393\u20132402."},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Zhang C, Han X, Yang L, Fu J, Sun C, Huang S, et al. Circular RNA circPPM1F modulates M1 macrophage activation and pancreatic islet inflammation in type 1 diabetes mellitus. Theranostics. 2020; 10: 10908\u201310924.","DOI":"10.7150\/thno.48264"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Gao P, Uzun Y, He B, Salamati SE, Coffey JKM, Tsalikian E, et al. Risk variants disrupting enhancers of TH1 and TREG cells in type 1 diabetes. Proceedings of the National Academy of Sciences of the United States of America. 2019; 116: 7581\u20137590.","DOI":"10.1073\/pnas.1815336116"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Suh KS, Chon S, Jung WW, Choi EM. Magnolol protects pancreatic \u03b2-cells against methylglyoxal-induced cellular dysfunction. Chemico-biological Interactions. 2017; 277: 101\u2013109.","DOI":"10.1016\/j.cbi.2017.09.014"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Qian S, Qian Y, Huo D, Wang S, Qian Q. Tanshinone IIa protects retinal endothelial cells against mitochondrial fission induced by methylglyoxal through glyoxalase 1. European Journal of Pharmacology. 2019; 857: 172419.","DOI":"10.1016\/j.ejphar.2019.172419"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Wang Z, Zhang J, Chen L, Li J, Zhang H, Guo X. Glycine Suppresses AGE\/RAGE Signaling Pathway and Subsequent Oxidative Stress by Restoring Glo1 Function in the Aorta of Diabetic Rats and in HUVECs. Oxidative Medicine and Cellular Longevity. 2019; 2019: 4628962.","DOI":"10.1155\/2019\/4628962"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Ahmad S, Uddin M, Habib S, Shahab U, Alam K, Ali A. Autoimmune response to AGE modified human DNA: Implications in type 1 diabetes mellitus. Journal of Clinical & Translational Endocrinology. 2014; 1: 66\u201372.","DOI":"10.1016\/j.jcte.2014.05.002"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Peppa M, He C, Hattori M, McEvoy R, Zheng F, Vlassara H. Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice. Diabetes. 2003; 52: 1441\u20131448.","DOI":"10.2337\/diabetes.52.6.1441"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Lai SWT, Lopez Gonzalez EDJ, Zoukari T, Ki P, Shuck SC. Methylglyoxal and Its Adducts: Induction, Repair, and Association with Disease. Chemical Research in Toxicology. 2022; 35: 1720\u20131746.","DOI":"10.1021\/acs.chemrestox.2c00160"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Almajwal AM, Alam I, Abulmeaty M, Razak S, Pawelec G, Alam W. Intake of dietary advanced glycation end products influences inflammatory markers, immune phenotypes, and antiradical capacity of healthy elderly in a little-studied population. Food Science & Nutrition. 2020; 8: 1046\u20131057.","DOI":"10.1002\/fsn3.1389"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Chen Y, Filipov NM, Guo TL. Dietary Glycation Products Regulate Immune Homeostasis: Early Glycation Products Promote Prostate Cancer Cell Proliferation through Modulating Macrophages. Molecular Nutrition & Food Research. 2018; 62:","DOI":"10.1002\/mnfr.201700641."},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Schalkwijk CG, Stehouwer CDA. Methylglyoxal, a Highly Reactive Dicarbonyl Compound, in Diabetes, Its Vascular Complications, and Other Age-Related Diseases. Physiological Reviews. 2020; 100: 407\u2013461.","DOI":"10.1152\/physrev.00001.2019"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Lohmann T, Laue S, Nietzschmann U, Kapellen TM, Lehmann I, Schroeder S, et al. Reduced expression of Th1-associated chemokine receptors on peripheral blood lymphocytes at diagnosis of type 1 diabetes. Diabetes. 2002; 51: 2474\u20132480.","DOI":"10.2337\/diabetes.51.8.2474"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Moraru A, Wiederstein J, Pfaff D, Fleming T, Miller AK, Nawroth P, et al. Elevated Levels of the Reactive Metabolite Methylglyoxal Recapitulate Progression of Type 2 Diabetes. Cell Metabolism. 2018; 27: 926\u2013934.e8.","DOI":"10.1016\/j.cmet.2018.02.003"},{"key":"ref20","unstructured":"Prada C LD, Nakaya H. Version 1.12.0.2022. MetaVolcanoR: Gene Expression Meta-analysis Visualization Tool. In R package; 2023. Available at: https:\/\/www.bioconductor.org\/packages\/release\/bioc\/htsml\/MetaVolcanoR.html (Accessed: 01 March 2023)."},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics: a Journal of Integrative Biology. 2012; 16: 284\u2013287.","DOI":"10.1089\/omi.2011.0118"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Yang M, Ye L, Wang B, Gao J, Liu R, Hong J, et al. Decreased miR-146 expression in peripheral blood mononuclear cells is correlated with ongoing islet autoimmunity in type 1 diabetes patients 1miR-146. Journal of Diabetes. 2015; 7: 158\u2013165.","DOI":"10.1111\/1753-0407.12163"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Stechova K, Kolar M, Blatny R, Halbhuber Z, Vcelakova J, Hubackova M, et al. Healthy first-degree relatives of patients with type 1 diabetes exhibit significant differences in basal gene expression pattern of immunocompetent cells compared to controls: expression pattern as predeterminant of autoimmune diabetes. Scandinavian Journal of Immunology. 2012; 75: 210\u2013219.","DOI":"10.1111\/j.1365-3083.2011.02637.x"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Kaizer EC, Glaser CL, Chaussabel D, Banchereau J, Pascual V, White PC. Gene expression in peripheral blood mononuclear cells from children with diabetes. The Journal of Clinical Endocrinology and Metabolism. 2007; 92: 3705\u20133711.","DOI":"10.1210\/jc.2007-0979"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Ogrotis I, Koufakis T, Kotsa K. Changes in the Global Epidemiology of Type 1 Diabetes in an Evolving Landscape of Environmental Factors: Causes, Challenges, and Opportunities. Medicina (Kaunas, Lithuania). 2023; 59: 668.","DOI":"10.3390\/medicina59040668"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Takehana N, Fukui T, Mori Y, Hiromura M, Terasaki M, Ohara M, et al. Comparison of positive rates between glutamic acid decarboxylase antibodies and ElisaRSR\u2122 3 Screen ICA\u2122 in recently obtained sera from patients who had been previously diagnosed with slowly progressive type 1 diabetes. Journal of Diabetes Investigation. 2023; 14: 856\u2013863.","DOI":"10.1111\/jdi.14016"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Vecchio F, Lo Buono N, Stabilini A, Nigi L, Dufort MJ, Geyer S, et al. Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes. JCI Insight. 2018; 3: e122146.","DOI":"10.1172\/jci.insight.122146"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Yin M, O\u2019Neill LAJ. The role of the electron transport chain in immunity. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology. 2021; 35: e21974.","DOI":"10.1096\/fj.202101161R"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Alharthy KM, Althurwi HN, Albaqami FF, Altharawi A, Alzarea SI, Al-Abbasi FA, et al. Barbigerone Potentially Alleviates Rotenone-Activated Parkinson\u2019s Disease in a Rodent Model by Reducing Oxidative Stress and Neuroinflammatory Cytokines. ACS Omega. 2023; 8: 4608\u20134615.","DOI":"10.1021\/acsomega.2c05837"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Peters E, Schirris T, van Asbeck AH, Gerretsen J, Eymael J, Ashikov A, et al. Effects of a human recombinant alkaline phosphatase during impaired mitochondrial function in human renal proximal tubule epithelial cells. European Journal of Pharmacology. 2017; 796: 149\u2013157.","DOI":"10.1016\/j.ejphar.2016.12.034"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Shin A, Connolly S, Kabytaev K. Protein glycation in diabetes mellitus. Advances in Clinical Chemistry. 2023; 113: 101\u2013156.","DOI":"10.1016\/bs.acc.2022.11.003"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Du C, Whiddett RO, Buckle I, Chen C, Forbes JM, Fotheringham AK. Advanced Glycation End Products and Inflammation in Type 1 Diabetes Development. Cells. 2022; 11: 3503.","DOI":"10.3390\/cells11213503"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Durning SP, Preston-Hurlburt P, Clark PR, Xu D, Herold KC, Type 1 Diabetes TrialNet Study Group. The Receptor for Advanced Glycation Endproducts Drives T Cell Survival and Inflammation in Type 1 Diabetes Mellitus. Journal of Immunology (Baltimore, Md.: 1950). 2016; 197: 3076\u20133085.","DOI":"10.4049\/jimmunol.1600197"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Plowman TJ, Shah MH, Fernandez E, Christensen H, Aiges M, Ramana KV. Role of Innate Immune and Inflammatory Responses in the Development of Secondary Diabetic Complications. Current Molecular Medicine. 2023; 23: 901\u2013920.","DOI":"10.2174\/1566524023666220922114701"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Yan SF, Ramasamy R, Schmidt AM. The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. Circulation Research. 2010; 106: 842\u2013853.","DOI":"10.1161\/CIRCRESAHA.109.212217"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Ostrand-Rosenberg S, Huecksteadt T, Sanders K. The Receptor for Advanced Glycation Endproducts (RAGE) and Its Ligands S100A8\/A9 and High Mobility Group Box Protein 1 (HMGB1) Are Key Regulators of Myeloid-Derived Suppressor Cells. Cancers. 2023; 15: 1026.","DOI":"10.3390\/cancers15041026"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Brouwers O, Niessen PMG, Miyata T, \u00d8stergaard JA, Flyvbjerg A, Peutz-Kootstra CJ, et al. Glyoxalase-1 overexpression reduces endothelial dysfunction and attenuates early renal impairment in a rat model of diabetes. Diabetologia. 2014; 57: 224\u2013235.","DOI":"10.1007\/s00125-013-3088-5"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Wang H, Meng QH, Gordon JR, Khandwala H, Wu L. Proinflammatory and proapoptotic effects of methylglyoxal on neutrophils from patients with type 2 diabetes mellitus. Clinical Biochemistry. 2007; 40: 1232\u20131239.","DOI":"10.1016\/j.clinbiochem.2007.07.016"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Reichert O, Fleming T, Neufang G, Schmelz M, Genth H, Kaever V, et al. Impaired glyoxalase activity is associated with reduced expression of neurotrophic factors and pro-inflammatory processes in diabetic skin cells. Experimental Dermatology. 2017; 26: 44\u201350.","DOI":"10.1111\/exd.13118"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Sun Y, Zhu Y, Liu X, Chai Y, Xu J. Morroniside attenuates high glucose-induced BMSC dysfunction by regulating the Glo1\/AGE\/RAGE axis. Cell Proliferation. 2020; 53: e12866.","DOI":"10.1111\/cpr.12866"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Hsieh MS, Chan WH. Impact of methylglyoxal and high glucose co-treatment on human mononuclear cells. International Journal of Molecular Sciences. 2009; 10: 1445\u20131464.","DOI":"10.3390\/ijms10041445"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Thornalley PJ, Edwards LG, Kang Y, Wyatt C, Davies N, Ladan MJ, et al. Antitumour activity of S-p-bromobenzylglutathione cyclopentyl diester in vitro and in vivo. Inhibition of glyoxalase I and induction of apoptosis. Biochemical Pharmacology. 1996; 51: 1365\u20131372.","DOI":"10.1016\/0006-2952(96)00059-7"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Wu L. The pro-oxidant role of methylglyoxal in mesenteric artery smooth muscle cells. Canadian Journal of Physiology and Pharmacology. 2005; 83: 63\u201368.","DOI":"10.1139\/y04-112"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Wong A, L\u00fcth HJ, Deuther-Conrad W, Dukic-Stefanovic S, Gasic-Milenkovic J, Arendt T, et al. Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer\u2019s disease. Brain Research. 2001; 920: 32\u201340.","DOI":"10.1016\/S0006-8993(01)02872-4"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Chang PC, Chen TH, Chang CJ, Hou CC, Chan P, Lee HM. Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway. Kidney International. 2004; 65: 1664\u20131675.","DOI":"10.1111\/j.1523-1755.2004.00602.x"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/29\/2\/10.31083\/j.fbl2902085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T13:50:02Z","timestamp":1732715402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/29\/2\/10.31083\/j.fbl2902085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,22]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"alternative-id":["S2768-6701(23)01143-7"],"URL":"https:\/\/doi.org\/10.31083\/j.fbl2902085","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"type":"print","value":"2768-6701"},{"type":"electronic","value":"2768-6698"}],"subject":[],"published":{"date-parts":[[2024,2,22]]},"article-number":"85"}}